中文摘要：

前蛋白转化酶枯草溶菌素9（PCSK9）基因编码神经凋亡调节转化酶即NARC1,通过影响肝LDLR水平,在胆固醇代谢中发挥了重要的作用.其功能获得型突变使血浆胆固醇水平增高,而功能缺失型突变降低胆固醇水平.流行病学调查显示,高胆固醇血症是动脉粥样硬化和心脏病的主要危险因素.一些患者运用当前的降胆固醇药物治疗仍不能达到推荐的目标LDL水平,PCSK9作为新的降脂靶点引起了广泛的关注.本文将对PCSK9的结构、功能和药理学靶点进行综述.

英文摘要：

Hypercholesterolemia is a major risk factor for atherosclerosis and heart disease. Current cholesterol-limiting therapies fail in some patients, where additional therapeutic targets are needed. PCSK9 encodes a pro-protein convertase subtitisin/kexin type 9a that plays an important role in cholesterol metabolism by the modulation of LDL receptor levels in the liver. Gain-of-function mutations of PCSK9 resulted in elevated levels of LDL-cholesterol in the plasma. Loss-of-function mutations led to high levels of the LDL receptor and low LDL-cholesterol. This review focuses on the structure, functions and pharmacological targets of PCSK9.